These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11418655)

  • 21. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
    Hadj-Slimane R; Chelbi-Alix MK; Tovey MG; Bobé P
    J Interferon Cytokine Res; 2004 Dec; 24(12):717-28. PubMed ID: 15684739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
    Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR
    J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.
    Aung S; Graham BS
    J Immunol; 2000 Apr; 164(7):3487-93. PubMed ID: 10725701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct requirements for IFNs and STAT1 in NK cell function.
    Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
    J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES; Abrams SI
    J Immunol; 2000 May; 164(9):4941-54. PubMed ID: 10779805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes.
    Leite-de-Moraes MC; Herbelin A; Gouarin C; Koezuka Y; Schneider E; Dy M
    J Immunol; 2000 Oct; 165(8):4367-71. PubMed ID: 11035073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas ligand--caught between Scylla and Charybdis.
    Strasser A; O'Connor L
    Nat Med; 1998 Jan; 4(1):21-2. PubMed ID: 9427600
    [No Abstract]   [Full Text] [Related]  

  • 33. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas.
    Fogler WE; Volker K; Watanabe M; Wigginton JM; Roessler P; Brunda MJ; Ortaldo JR; Wiltrout RH
    J Immunol; 1998 Dec; 161(11):6014-21. PubMed ID: 9834083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen-dependent release of IFN-gamma by cytotoxic T cells up-regulates Fas on target cells and facilitates exocytosis-independent specific target cell lysis.
    Müllbacher A; Lobigs M; Hla RT; Tran T; Stehle T; Simon MM
    J Immunol; 2002 Jul; 169(1):145-50. PubMed ID: 12077239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions.
    Caldwell CC; Kojima H; Lukashev D; Armstrong J; Farber M; Apasov SG; Sitkovsky MV
    J Immunol; 2001 Dec; 167(11):6140-9. PubMed ID: 11714773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
    Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
    Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
    J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of Fas-mediated cytotoxicity and FasL expression in a cytotoxic CD4+ T-cell clone. Comparative analysis of Fas-mediated cytotoxicity between a T-hybridoma and a T-cell clone.
    Kaneda R; Iwabuchi K; Onoé K
    Immunol Lett; 1997 Jan; 55(1):53-60. PubMed ID: 9093882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.